CT SB 439: AN ACT REQUIRING MEDICAID COVERAGE FOR BONE MARROW AND STEM CELL TRANSPLANTS AND FDA-APPROVED GENE THERAPIES TO TREAT SICKLE CELL DISEASE.

Talk to us

Your feedback directly shapes Sporos.

CT SB 439: AN ACT REQUIRING MEDICAID COVERAGE FOR BONE MARROW AND STEM CELL TRANSPLANTS AND FDA-APPROVED GENE THERAPIES TO TREAT SICKLE CELL DISEASE. | Sporos

Talk to us

AN ACT REQUIRING MEDICAID COVERAGE FOR BONE MARROW AND STEM CELL TRANSPLANTS AND FDA-APPROVED GENE THERAPIES TO TREAT SICKLE CELL DISEASE.

AI Summary

Status